Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | GLIX1 |
| Synonyms | |
| Therapy Description |
GLIX1 is a small molecule targeting TET2 and the DNA damage response pathway, potentially leading to tumor cell death (Neuro Oncol 25(Suppl 5):v109). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| GLIX1 | GLIX1 is a small molecule targeting TET2 and the DNA damage response pathway, potentially leading to tumor cell death (Neuro Oncol 25(Suppl 5):v109). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07464925 | Phase I | GLIX1 | A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma | Not yet recruiting | USA | 0 |